ClinicalTrials.Veeva

Menu

Formula Identification (FID) 114657 in Contact Lens Wearers

Alcon logo

Alcon

Status

Completed

Conditions

Refractive Error

Treatments

Drug: Saline control eye drops (15 ml)
Drug: FID 114657 eye drops (10 ml)
Device: Habitual contact lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT02293538
LCO242-P001

Details and patient eligibility

About

The purpose of this study is to evaluate the thickness of the pre-lens tear lipid layer after 2 hours of lens wear with use of FID 114657 compared to saline control.

Enrollment

234 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must sign the informed consent form.
  • Stable, tear lipid layer thickness ≤ 75 nm without contact lenses.
  • Successfully wearing bi-weekly or monthly replacement soft contact lenses in both eyes for a minimum of 5 days/week during the past 2 months prior to Visit 1.
  • Vision correctable to 20/25 Snellen (feet) or better at distance with habitual contact lenses at Visit 1.
  • Willing to wear lenses 5 days a week, 8 hours a day for at least 2 days during the study.
  • Demonstrate symptoms of contact lens discomfort.
  • Other protocol-defined inclusion criteria may apply.

Exclusion criteria

  • Routinely sleeping in lenses.
  • Any active eye inflammation or condition that contraindicates contact lens wear.
  • Any systemic diseases that could prevent successful contact lens wear.
  • Use of systemic or ocular medications that contraindicate lens wear.
  • Fit with only 1 contact lens.
  • Unwilling to discontinue the use of cosmetics (such as eyeliner, mascara, or eye shadow) or facial creams on or around the eyelids on Day 1 and Day 14 of the study.
  • Women of childbearing potential who are currently pregnant, test positive for pregnancy at Screening visit, breast feeding, or unwilling to use adequate birth control throughout the study.
  • Other protocol-defined exclusion criteria may apply.

Trial design

234 participants in 2 patient groups

FID 114657
Experimental group
Description:
FID 114657 eye drops (10 ml), 1-2 drops instilled in each eye 10 minutes prior to inserting a new pair of habitual contact lenses and after removing them, daily for 2 weeks.
Treatment:
Device: Habitual contact lenses
Drug: FID 114657 eye drops (10 ml)
Saline Control
Active Comparator group
Description:
Saline control eye drops (15 ml), 1-2 drops instilled in each eye 10 minutes prior to inserting a new pair of habitual contact lenses and after removing them, daily for 2 weeks.
Treatment:
Drug: Saline control eye drops (15 ml)
Device: Habitual contact lenses

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems